Advertisement

Outcomes of Metabolic Surgery

  • Francesco Rubino
  • Ashwin Soni
  • Alpana Shukla
Chapter

Abstract

The concept of “metabolic surgery” has evolved to indicate a surgical approach aimed at controlling of metabolic illnesses, and not just excess weight. Demographic characteristics, prevalence, and severity of diabetes and cardiovascular disease differ substantially in patients who present for metabolic surgery compared to those who seek conventional bariatric surgery for weight loss. Such differences have important ramifications for preoperative and postoperative patient management as well as outcomes of metabolic surgery. While for decades excess weight loss (EWL) has been a traditional measure of the efficacy of bariatric surgery, remission/improvement of metabolic disease (type 2 diabetes mellitus, hypertension, obstructive sleep apnea, dyslipidemia) and cardiovascular risk reduction are more rational measures of outcomes in metabolic surgery. This chapter aims to define the role of metabolic surgery, review the effects of gastrointestinal surgery on metabolic outcomes from retrospective and observational studies, and review the outcomes of metabolic surgery from prospective randomized controlled trial data.

Keywords

Obstructive Sleep Apnea Bariatric Surgery Gastric Bypass Sleeve Gastrectomy Laparoscopic Sleeve Gastrectomy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Rubino F, Schauer PR, Kaplan LM, Cummings DE. Metabolic surgery to treat type 2 diabetes: clinical outcomes and mechanisms of action. Annu Rev Med. 2010;61:393–411.PubMedCrossRefGoogle Scholar
  2. 2.
    Rubino F, Kaplan LM, Schauer PR, Cummings DE, Diabetes Surgery Summit Delegates. The Diabetes Surgery Summit consensus conference: recommendations for the evaluation and use of gastrointestinal surgery to treat type 2 diabetes mellitus. Ann Surg. 2010;251(3):399–405.PubMedCrossRefGoogle Scholar
  3. 3.
    Dixon JB, Zimmet P, Alberti KG, Rubino F, International Diabetes Federation Taskforce on Epidemiology and Prevention. Bariatric surgery: an IDF statement for obese Type 2 diabetes. Diabet Med. 2011;28(6):628–42.PubMedCrossRefPubMedCentralGoogle Scholar
  4. 4.
    Sjöström L, Lindroos AK, Peltonen M, Torgerson J, Bouchard C, Carlsson B, et al.; Swedish Obese Subjects Study Scientific Group. Lifestyle, diabetes and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004;351(26):2683–93.Google Scholar
  5. 5.
    Pories WJ, Swanson MS, MacDonald KG, Long SB, Morris PG, Brown BM, et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg. 1995;222:339–50.PubMedCrossRefPubMedCentralGoogle Scholar
  6. 6.
    Schauer PR, Burguera B, Ikramuddin S, Cottam D, Gourash W, Hamad G, et al. Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus. Ann Surg. 2003;238(4):467–84.PubMedPubMedCentralGoogle Scholar
  7. 7.
    Gill RS, Birch DW, Shi X, Sharma AM, Karmali S. Sleeve gastrectomy and type 2 diabetes mellitus: a systematic review. Surg Obes Relat Dis. 2010;6(6):707–13.PubMedCrossRefGoogle Scholar
  8. 8.
    Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292(14):1724–37.PubMedCrossRefGoogle Scholar
  9. 9.
    Pournaras DJ, Aasheim ET, Søvik TT, Andrews R, Mahon D, Welbourn R, et al. Effect of the definition of type II diabetes remission in the evaluation of bariatric surgery for metabolic disorders. Br J Surg. 2012;99(1):100–3.PubMedCrossRefGoogle Scholar
  10. 10.
    Nguyen NT, Varela E, Sabio A, Tran CL, Stamos M, Wilson SE. Resolution of hyperlipidemia after laparoscopic Roux-en-Y gastric bypass. J Am Coll Surg. 2006;203(1):24–9.PubMedCrossRefGoogle Scholar
  11. 11.
    Vila M, Ruíz O, Belmonte M, Riesco M, Barceló A, Perez G, et al. Changes in lipid profile and insulin resistance in obese patients after Scopinaro biliopancreatic diversion. Obes Surg. 2009;19(3): 299–306.PubMedCrossRefGoogle Scholar
  12. 12.
    Jamal M, Wegner R, Heitshusen D, Liao J, Samuel I. Resolution of hyperlipidemia follows surgical weight loss in patients undergoing Roux-en-Y gastric bypass surgery: a 6-year analysis of data. Surg Obes Relat Dis. 2011;7(4):473–9.PubMedCrossRefGoogle Scholar
  13. 13.
    Brolin R, Kenler HA, Wilson AC, Kuo PT, Cody RP. Serum lipids after gastric bypass surgery for morbid obesity. Int J Obes. 1990; 14(11):939–50.PubMedGoogle Scholar
  14. 14.
    Scopinaro N, Marinari GM, Camerini GB, Papadia FS, Adami GF. Specific effects of biliopancreatic diversion on the major components of metabolic syndrome. Diabetes Care. 2005;28(10): 2406–11.PubMedCrossRefGoogle Scholar
  15. 15.
    Hinojosa MW, Varela JE, Smith BR, Che F, Nguyen NT. Resolution of systemic hypertension after laparoscopic gastric bypass. J Gastrointest Surg. 2009;13:793–7.PubMedCrossRefGoogle Scholar
  16. 16.
    Ahmed AR, Rickards G, Coniglio D, Xia Y, Johnson J, Boss T, et al. Laparoscopic Roux-en-Y gastric bypass and its early effect on blood pressure. Obes Surg. 2009;19:845–9.PubMedCrossRefGoogle Scholar
  17. 17.
    Sarkhosh K, Birch DW, Shi X, Gill RS, Karmali S. The impact of sleeve gastrectomy on hypertension: a systematic review. Obes Surg. 2012;22:832–7.PubMedCrossRefGoogle Scholar
  18. 18.
    Coughlin SR, Mawdsley L, Mugarza JA, Calverley PM, Wilding JP. Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome. Eur Heart J. 2004;25(9):735–41.PubMedCrossRefGoogle Scholar
  19. 19.
    Foster GD, Borradaile KE, Sanders MH, Millman R, Zammit G, Newman AB, et al.; Sleep AHEAD Research Group of Look AHEAD Research Group. A randomized study on the effect of weight loss on obstructive sleep apnea among obese patients with type 2 diabetes. Arch Intern Med. 2009;169(17):1619–26.Google Scholar
  20. 20.
    Lettieri CJ, Eliasson AH, Greenburg DL. Persistence of obstructive sleep apnea after surgical weight loss. J Clin Sleep Med. 2008;4(4): 333–8.PubMedPubMedCentralGoogle Scholar
  21. 21.
    Greenburg DL, Lettieri CJ, Eliasson AH. Effects of surgical weight loss on measures of obstructive sleep apnea: a meta-analysis. Am J Med. 2009;122(6):535–42.PubMedCrossRefGoogle Scholar
  22. 22.
    Kalra M, Inge T. Effect of bariatric surgery on obstructive sleep apnoea in adolescents. Paediatr Respir Rev. 2006;7(4):260–7.PubMedCrossRefGoogle Scholar
  23. 23.
    Escobar-Morreale HF, Botella-Carretero JI, Álvarez-Blasco F, Sancho J, San Millán JL. The polycystic ovary syndrome associated with morbid obesity may resolve after weight loss induced by bariatric surgery. J Clin Endocrinol Metab. 2005;90(12):6364–9.PubMedCrossRefGoogle Scholar
  24. 24.
    Gosman GG, King WC, Schrope B, Steffen KJ, Strain GW, Courcoulas AP, et al. Reproductive health of women electing bariatric surgery. Fertil Steril. 2010;94(4):1426–31.PubMedCrossRefPubMedCentralGoogle Scholar
  25. 25.
    Eid GM, Cottam DR, Velcu LM, Mattar SG, Korytkowski MT, Gosman G, et al. Effective treatment of polycystic ovarian syndrome with Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2005; 1(2):77–80.PubMedCrossRefGoogle Scholar
  26. 26.
    Adams TD, Gress RE, Smith SC, Halverson RC, Simper SC, Rosamond WD, et al. Long-term mortality after gastric bypass surgery. N Engl J Med. 2007;357(8):753–61.PubMedCrossRefGoogle Scholar
  27. 27.
    Dixon JB, O’Brien PE, Playfair J, Chapman L, Schachter LM, Skinner S, et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA. 2008;299(3):316–23.PubMedCrossRefGoogle Scholar
  28. 28.
    Mingrone G, Panunzi S, De Gaetano A, Guidone C, Iaconelli A, Leccesi L, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med. 2012;366(17):1577–85.PubMedCrossRefGoogle Scholar
  29. 29.
    Schauer PR, Kashyap SR, Wolski K, Brethauer SA, Kirwan JP, Pothier CE, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med. 2012;366(17):1567–76.PubMedCrossRefPubMedCentralGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2015

Authors and Affiliations

  1. 1.Bariatric and Metabolic Surgery, King’s College London ConsultantKing’s College HospitalLondonUK
  2. 2.Section of Gastrointestinal Metabolic SurgeryWeill Cornell Medical College, New York Presbyterian HospitalNew YorkUSA
  3. 3.Section of Gastrointestinal Metabolic Surgery, Department of SurgeryWeill Cornell Medical College, New York Presbyterian HospitalNew YorkUSA

Personalised recommendations